Correct Answer: A. Intravenous fluids with regular insulin
This patient presents with diabetic ketoacidosis (DKA) — a life-threatening emergency characterized by hyperglycemia (500 mg/dL), ketonemia, and metabolic acidosis. The management of DKA has two simultaneous pillars: aggressive fluid resuscitation and insulin therapy. IV fluids alone (option B) correct dehydration and dilute hyperglycemia but do NOT address the underlying ketoacidosis or halt ketone production — insulin is mandatory to suppress lipolysis and ketogenesis. Regular (short-acting) insulin is the only appropriate choice because: (1) it has rapid onset (15–30 min IV), allowing titration in a life-threatening emergency; (2) it can be discontinued immediately if hypoglycemia develops; (3) long-acting insulins (glargine, detemir) have delayed onset and cannot be reversed, making them dangerous in acute DKA. The standard protocol per Indian guidelines (RNTCP, IAP) and Harrison is: 0.1 U/kg bolus of regular insulin IV, followed by 0.1 U/kg/hr infusion, adjusted based on glucose and ketone clearance. Fluids (0.9% saline, 1–1.5 L/hr initially) restore intracellular volume and renal perfusion, enabling insulin efficacy and ketone clearance. Both interventions must begin simultaneously in DKA.
Why the other options are wrong
B. Intravenous fluids — While IV fluids are essential for rehydration and glucose dilution, fluids alone do NOT suppress lipolysis or halt ketone production. Without insulin, the patient remains in a state of uncontrolled ketogenesis, perpetuating metabolic acidosis and risking cardiovascular collapse. This is a common trap — students may think fluids 'buy time,' but DKA is a medical emergency requiring simultaneous insulin initiation. C. Intravenous fluids with long-acting insulin — Long-acting insulins (glargine, detemir) have an onset of 1–4 hours and peak effect at 8–24 hours — far too slow for acute DKA. They cannot be titrated or rapidly reversed if hypoglycemia occurs, making them contraindicated in emergency settings. This option tests whether students confuse chronic diabetes management (where long-acting insulin is standard) with acute DKA management (where rapid reversibility is critical). D. Intravenous insulin — This option omits IV fluids, which are equally critical in DKA. Fluids restore circulating volume, improve renal perfusion, and enable insulin to work effectively. Insulin without fluids risks worsening dehydration and acute kidney injury. The question stem emphasizes dehydration ('appears dehydrated'), making fluid resuscitation non-negotiable alongside insulin.
High-Yield Facts
- DKA diagnostic triad: blood glucose >250 mg/dL, arterial pH <7.30, and serum/urine ketones — all three must be present.
- Regular insulin IV is the only insulin formulation safe in acute DKA because of rapid onset (15–30 min), short half-life (5–10 min), and reversibility.
- Initial fluid bolus in DKA: 0.9% saline 1–1.5 L/hr for first 1–2 hours, then 250–500 mL/hr based on hemodynamics and urine output.
- Insulin dosing in DKA: 0.1 U/kg IV bolus, then 0.1 U/kg/hr infusion; glucose target is 150–250 mg/dL (NOT normoglycemia) to prevent hypoglycemia while clearing ketones.
- Potassium monitoring is critical: insulin shifts K+ intracellularly, causing hypokalemia; serum K+ must be checked every 2–4 hours and replaced if <5.5 mEq/L.
Mnemonics
DKA Management: FLUIDS + INSULIN Fluids (0.9% saline, 1–1.5 L/hr) + Insulin (regular, IV, 0.1 U/kg bolus then infusion) + K+ monitoring (replace if <5.5) + Acetone clearance (monitor VBG/ABG) + Support (ICU, continuous monitoring). Both fluids and regular insulin must start simultaneously. Why NOT long-acting insulin in DKA? SLOW — Long-acting insulins have delayed onset (1–4 hr) and cannot be reversed. SAFE — Regular insulin is rapid (15–30 min) and reversible. In emergencies, always choose rapid + reversible.
NBE Trap
NBE pairs 'IV fluids' alone (option B) with DKA to trap students who recognize the need for fluids but forget that insulin is equally mandatory to suppress ketogenesis. The question stem emphasizes dehydration to make fluids seem sufficient, but DKA requires both simultaneously.
Clinical Pearl
In Indian emergency departments, DKA is often underrecognized in young, non-compliant diabetic patients presenting with vomiting and abdominal pain. The classic teaching is: fluids restore perfusion, insulin stops ketone production — both are non-negotiable. Delaying insulin while waiting for 'full rehydration' risks cardiovascular collapse and cerebral edema.
_Reference: Harrison Ch. 397 (Diabetes Mellitus); KD Tripathi Ch. 28 (Insulin & Oral Hypoglycemics); Robbins Ch. 24 (Endocrine Pathology)_